Table 1.

Scoring of arthritis best practices for 3 case scenarios [moderate knee osteoarthritis (OA), early and late rheumatoid arthritis (RA)].

Best PracticesModerate Knee OAEarly RALate RA
EducationProvided education or educational materials or contacts for further information (e.g., support groups, The Arthritis Society, Arthritis Society help line (1 800 line) or website, Arthritis Self Management Program)111
Exercise/PTProvided or recommended exercise or physical activity or referred to an exercise program or to a physiotherapist111
Joint protection/OT/assistive devicesProvided instruction in joint protection or energy conservation techniques or recommended or referred to an occupational therapist. Provided a device or recommended or referred to rehabilitation specialist for assistive devices (e.g., canes, crutches, or walkers to improve ambulation)111
SW/social supportInquired about or discussed social support and coping strategies, provided or recommended or referred to a social worker/psychologist, psychiatrist, or mental health worker/counselor11
Weight managementProvided information on maintaining a healthy weight, healthy eating, nutrition, or assessed body mass index/waist circumference/weight1
AnalgesicsPrescribed or recommended or referred for analgesics (e.g., acetaminophen, glucosamine, capsaicin cream, acupuncture)1
NSAIDConsidered, prescribed, or referred for nonsteroidal antiinflammatory drugs (NSAID), advancing to higher doses as necessary111
Intraarticular injectionsConsidered, prescribed, or referred for intraarticular corticosteroids or hyaluronans1
Rheumatology referralDiscussed or considered or made a referral to an arthritis specialist (rheumatologist, internist)11
DMARDDiscussed or recommended or prescribed or referred for a disease-modifying antirheumatic drug (DMARD)11
OrthopedicsDiscussed or considered or made a referral to an orthopedic surgeon11
Total points878
  • PT: physical therapy; OT: occupational therapy; SW: social worker; NSAID: nonsteroidal antiinflammatory drugs; DMARD: disease modifying antirheumatic drugs.